BEZ235
Description: An experimental anticancer drug, also called dactolisib, that inhibits phosphoinositide 3-kinase and mammalian target of rapamycin signaling.
Primary topic: PI3K/AKT/mTOR signaling in cancer (41%)
Related topic: PI3K/AKT/mTOR signaling in cancer (41%)
Wikidata ID: wiki/Q4835503
OpenAlex ID: keywords/bez235
